Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.
about
Psychoactive 'bath salts': compounds, mechanisms, and toxicitiesEffects of social interaction and warm ambient temperature on brain hyperthermia induced by the designer drugs methylone and MDPV.Ethylone-Related Deaths: Toxicological FindingsPotent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)Pharmacological characterization of designer cathinones in vitroSubstituted methcathinones differ in transporter and receptor interactionsInternational society for disease surveillance conference 2011: building the future of public health surveillanceDesigner drugs 2015: assessment and management.Patterns of Use, Acute Subjective Experiences, and Motivations for Using Synthetic Cathinones ("Bath Salts") in Recreational Users.In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.Using poisons information service data to assess the acute harms associated with novel psychoactive substances.Incidents of potential public health significance identified using national surveillance of US poison center data (2008-2012)Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related AnalogsEmerging drugs of abuse: current perspectives on substituted cathinones.Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology.Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine.A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public (ill)health. Legal highs or illegal highs?3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry.Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs.Prevalence of new psychoactive substances: A retrospective study in hair.Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification.Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones.Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results.Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporterA case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug."Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter.Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology.3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.The new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity.Baths salts, spice, and related designer drugs: the science behind the headlines.Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in ratsInvestigation of "bath salts" use patterns within an online sample of users in the United States.Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence.Effects of α-pyrrolidinopentiophenone and 4-methyl-N-ethylcathinone, two synthetic cathinones commonly found in second-generation "bath salts," on intracranial self-stimulation thresholds in rats.Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry.Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues.Synthetic cathinones: a new public health problemAcute Methylenedioxypyrovalerone Toxicity.
P2860
Q26830900-D20143A9-B701-468F-8219-0ED212243F45Q27311250-39DD7BFB-8147-4871-B842-060F2A65CC31Q28262614-72792F72-CF15-465C-8C3F-877D833888ACQ28270808-9796436D-2D19-4138-AE11-958836DEF5D9Q28273207-0DE841DC-BE5C-43DB-8B8A-EEFA70501AA8Q28288908-B5A07BD8-0212-4442-9527-8E2737126842Q28732714-DBD60F65-BC73-47C3-8B53-23F5AB07989AQ30300017-199D0F7B-EDF7-4A40-B97B-4B8A7928420BQ30393519-221813A7-9F5D-4377-A841-7BB2148DFBA3Q30535782-3C9B91C4-06D2-4FFD-9254-1F3D05A01149Q30821795-6E1D388B-F3DB-4A47-B0B4-5C0343AC1254Q30846838-4090EDAF-A9A7-40EF-A333-F8235B2353E2Q33566201-8E351994-77D2-4DFC-B7CB-D9A44DB6573AQ33706892-A2996C0C-D5F5-47F2-A3C5-9F922D233B61Q33725088-F8D43D77-D255-4F02-8280-1D07CA2D45FEQ33934379-A1E69060-54F4-44AF-8042-8B6D44706B02Q34030028-62DD018C-0C04-49B2-A2D4-D2A51CEE26D4Q34033024-9ABD80B9-7823-4DE2-8897-FD467DE5A048Q34115248-BC509771-736C-46C6-9A07-7B7B35C300F0Q34122902-F166A4B2-5BD2-4841-A836-EFE36EAB8CCFQ34267407-16D30635-8DBB-4924-AE3B-D6C53F8C0B57Q34270004-1DB5BB0F-A452-46E8-AE73-11F71EC4A943Q34270487-32D84E70-9A26-49B5-87EC-0F302A88CF88Q34280393-A786A522-87FD-45EB-ADDC-C7F7C1C8AF09Q34325173-F68D3449-5CB4-4138-9E6D-B9828A807E77Q34325588-BFA53F48-1552-43FF-BC60-4AC7CD10276BQ34331924-EB94AA2C-4D95-43B2-9BAA-2889302656B1Q34377086-4F3C1A59-2EE5-4718-BD19-D627B8CDD06BQ34385110-5A4067F7-9E40-41E6-BF89-842CCB62E36EQ34459984-4378BC9D-2544-486A-9BB0-AA3587B33E10Q34490243-59482FDC-A3D5-4177-A1BA-CCDB75BC672FQ34491601-FF83961B-A7D2-439E-8EA8-A3DC142657F7Q34507647-2BC5C3A4-E776-469B-A932-F471A0E0C4C2Q34701207-6FC0579E-667B-4846-ACE3-2B37689816A3Q34756340-55477AE0-E220-4677-BE18-F457AF3085FAQ35203582-9C644317-F9F4-49E7-9377-0A32F06851D6Q35536635-61D88C90-86FD-4243-99F0-40CFA3BED0BBQ35538485-F596C425-9EA3-4E1B-B04F-6713E467AB91Q35710543-F1F2335E-061D-474D-9D52-6955D2C5FE18Q35749136-CAAF5A74-8F75-46A3-86DB-94D0FE4B7644
P2860
Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinical experience with and a ...... hinones) in the United States.
@ast
Clinical experience with and a ...... hinones) in the United States.
@en
Clinical experience with and analytical confirmation of "bath salts" and "legal highs"
@nl
type
label
Clinical experience with and a ...... hinones) in the United States.
@ast
Clinical experience with and a ...... hinones) in the United States.
@en
Clinical experience with and analytical confirmation of "bath salts" and "legal highs"
@nl
prefLabel
Clinical experience with and a ...... hinones) in the United States.
@ast
Clinical experience with and a ...... hinones) in the United States.
@en
Clinical experience with and analytical confirmation of "bath salts" and "legal highs"
@nl
P2093
P2860
P1433
P1476
Clinical experience with and a ...... hinones) in the United States.
@en
P2093
Henry A Spiller
Joanne Jansen
Mark L Ryan
Robert G Weston
P2860
P304
P356
10.3109/15563650.2011.590812
P407
P577
2011-07-01T00:00:00Z